Skip to content

Solomon Moshkevich, President, Clinicaldiagnostics at Natera, sold NTRA on Oct 1, 2026

Data as of Oct 16

▼ SELL$82.3K200 shares at $411.62Solomon Moshkevich President, ClinicaldiagnosticsNTRA Natera, Inc.
Watch NTRA
Traded
Oct 1, 2026
Disclosed
Oct 2, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Solomon Moshkevich, President, Clinicaldiagnostics at Natera, sold NTRA on Oct 1, 2026TRADEDDISCLOSED
NTRASimilar stocks (XLV — its sector index fund), rebased to NTRA's price on the disclosure day
NTRA since disclosure
−4.1%
after the sale
Similar stocks (XLV) since disclosure
+6.3%
XLV — its sector index fund

Change in closing price from Oct 2, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLSolomon Moshkevich President, ClinicaldiagnosticsNTRA Natera, Inc.$766Kdisclosed Oct 2 · filed 1 day after the trade
  2. ▼ SELLSolomon Moshkevich President, ClinicaldiagnosticsNTRA Natera, Inc.$394Kdisclosed Oct 2 · filed 1 day after the trade

See every trade on NTRA →